Journal articles on the topic 'Skin Cancer Victoria Prevention'

To see the other types of publications on this topic, follow the link: Skin Cancer Victoria Prevention.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Skin Cancer Victoria Prevention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Shih, S., R. Carter, S. Heward, and C. Sinclair. "Costs Related to Skin Cancer Prevention in Victoria and Australia." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 9s. http://dx.doi.org/10.1200/jgo.18.10800.

Full text
Abstract:
Background: The aim of this presentation is to provide an update on the economic evaluation of the Australian SunSmart program as well as outline the cost of skin cancer treatment to the Victorian public hospital system. This follows the publication of two recently released published economic evaluations that discusses the potential effects of skin cancer prevention inventions. Aim: 1. To highlight the cost effectiveness of skin cancer prevention in Australia 2. To highlight the costs of skin cancer treatment in the Victorian public hospital system 3. To provide strong evidence to inform governments of the value of skin cancer prevention to reduce the costs of treatment in future years. Methods: Program cost was compared with cost savings to determine the investment return of the program. In a separate study, a prevalence-based cost approach was undertaken in public hospitals in Victoria. Costs were estimated for inpatient admissions, using state service statistics, and outpatient services based on attendance at three hospitals in 2012-13. Cost-effectiveness for prevention was estimated from 'observed vs expected' analysis, together with program expenditure data. Results: With additional $AUD 0.16 ($USD 0.12) per capita investment into skin cancer prevention across Australia from 2011 to 2030, an upgraded SunSmart Program would prevent 45,000 melanoma and 95,000 NMSC cases. Potential savings in future healthcare costs were estimated at $200 million, while productivity gains were significant. A future upgraded SunSmart Program was predicted to be cost-saving from the funder perspective, with an investment return of $3.20 for every additional dollar the Australian governments/funding bodies invested into the program. In relation to the costs to the Victorian public hospital system, total annual costs were $48 million to $56 million. Skin cancer treatment in public hospitals ($9.20∼$10.39 per head/year) was 30-times current public funding in skin cancer prevention ($0.37 per head/year). Conclusion: The study demonstrates the strong economic credentials of the SunSmart Program, with a strong economic rationale for increased investment. Increased funding for skin cancer prevention must be kept high on the public health agenda. This would also have the dual benefit of enabling hospitals to redirect resources to nonpreventable conditions.
APA, Harvard, Vancouver, ISO, and other styles
2

Raymond, W., D. Preen, H. Keen, C. Inderjeeth, and J. Nossent. "POS0769 CANCER DEVELOPMENT IN PATIENTS HOSPITALISED WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL, POPULATION-LEVEL DATA LINKAGE STUDY." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 671.2–671. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3999.

Full text
Abstract:
BackgroundThe association between systemic lupus erythematosus (SLE) and cancer risk is unclear.ObjectivesDescribe the association between systemic lupus erythematosus (SLE) and the risk of cancer development and subsequent 5-year mortality in Western Australia (WA).MethodsPopulation-level cohort study of SLE patients (n=2,111) and general population comparators (n=21,110) hospitalised between 1980–2014. SLE patients (identified by ICD-9-CM: 695.4, 710.0, and ICD-10-AM: L93.0, M32.0) were nearest matched (10:1) for age, sex, Aboriginality, and temporality. Follow-up was from timezero (index SLE hospitalisation) to cancer development, death or 31/12/2014. Using longitudinal linked health data, we determined the risk of cancer development and subsequent 5-year mortality between SLE patients and comparators with Cox proportional hazards regression models.ResultsSLE patients had similar multivariate-adjusted risk (aHR 1.03, 95%CI 0.93, 1.15; P=0.583) of cancer development. Cancer development risk was higher in SLE patients <40 years old (aHR 1.51), and from 1980-1999 (aHR 1.28). SLE patients had higher risk of developing cancer of the oropharynx (aHR 2.13); vulvo-vagina (aHR 3.22); skin (aHR 1.20), and, lymphatic and haematopoietic tissues (aHR 1.78), all P<0.05. SLE patients had reduced risk of breast cancer (aHR 0.64). After cancer development, SLE patients had increased risk of 5-year mortality (aHR 1.16, 95%CI 1.01, 1.33); highest in 40-49 years old (aHR 1.89), and in those with skin (aHR 1.65) or prostate cancer (aHR 4.74).ConclusionHospitalised SLE patients had increased risk of multiple cancers, but a reduced risk of breast cancer. Following cancer development, SLE patients had increased risk of 5-year mortality. Together there is scope to improve cancer prevention and surveillance in SLE patients.AcknowledgementsThe authors wish to thank the staff at the Western Australian Data Linkage Branch and Emergency Department Data Collection, Hospital Morbidity Data Collection, Western Australian Cancer Registry, and Death Registrations. The authors wish to thank the Australian Co-ordinating Registry, the Registries of Births, Deaths and Marriages, the Coroners, the National Coronial Information System and the Victorian Department of Justice and Community Safety for enabling COD URF data to be used for this publication.Disclosure of InterestsNone declared
APA, Harvard, Vancouver, ISO, and other styles
3

Taylor, Pamela, and Dr Dafydd Roberts. "Skin cancer prevention." Nursing Standard 11, no. 50 (September 3, 1997): 42–45. http://dx.doi.org/10.7748/ns.11.50.42.s50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hussain, Nazia A. "Skin cancer prevention." InnovAiT: Education and inspiration for general practice 6, no. 7 (July 2013): 447–52. http://dx.doi.org/10.1093/innovait_inr230.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Masterson, Katrina Nice. "Skin Cancer Prevention." Journal of the Dermatology Nurses’ Association 7, no. 2 (2015): 73–75. http://dx.doi.org/10.1097/jdn.0000000000000120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kornek, Thomas, and Matthias Augustin. "Skin cancer prevention." JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11, no. 4 (April 2013): 283–98. http://dx.doi.org/10.1111/ddg.12066.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Greinert, R. "Skin cancer prevention." European Journal of Cancer Prevention 10, no. 2 (April 2001): 123–24. http://dx.doi.org/10.1097/00008469-200104000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hansen, K. "Skin cancer prevention." Melanoma Research 6, SUPPLEMENT 1 (September 1996): S10. http://dx.doi.org/10.1097/00008390-199609001-00025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hill, David. "Skin cancer prevention." American Journal of Preventive Medicine 27, no. 5 (December 2004): 482–83. http://dx.doi.org/10.1016/j.amepre.2004.08.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

DELEO, VINCENT A. "Prevention of Skin Cancer." Journal of Dermatologic Surgery and Oncology 14, no. 8 (August 1988): 902–6. http://dx.doi.org/10.1111/j.1524-4725.1988.tb03594.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Lowe, John B. "Prevention of Skin Cancer." Cancer Causes & Control 15, no. 2 (March 2004): 221–22. http://dx.doi.org/10.1023/b:caco.0000019577.08892.02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Marrett, Loraine. "Prevention of Skin Cancer." Cancer Causes & Control 15, no. 3 (April 2004): 329–30. http://dx.doi.org/10.1023/b:caco.0000024314.53427.27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Sliney, David. "Prevention of Skin Cancer." Cancer Causes & Control 15, no. 6 (August 2004): 635. http://dx.doi.org/10.1023/b:caco.0000036205.30392.f1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Tripp, Mary K., Sally W. Vernon, Ellen R. Gritz, Pamela M. Diamond, and Patricia Dolan Mullen. "Children's Skin Cancer Prevention." American Journal of Preventive Medicine 44, no. 3 (March 2013): 265–73. http://dx.doi.org/10.1016/j.amepre.2012.10.027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Svoboda, Ryan M., Robert J. Friedman, and Darrell S. Rigel. "Skin Self-examination for Skin Cancer Prevention." JAMA 320, no. 7 (August 21, 2018): 720. http://dx.doi.org/10.1001/jama.2018.8008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Roberson, Kortnee. "Nicotinamide for skin cancer prevention." Evidence-Based Practice 19, no. 12 (December 2016): 4. http://dx.doi.org/10.1097/01.ebp.0000541572.51934.bc.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Shenefelt, Philip D. "SKIN CANCER PREVENTION AND SCREENING." Primary Care: Clinics in Office Practice 19, no. 3 (September 1992): 557–74. http://dx.doi.org/10.1016/s0095-4543(21)00938-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

&NA;. "Celecoxib for skin cancer prevention?" Inpharma Weekly &NA;, no. 1347 (July 2002): 6. http://dx.doi.org/10.2165/00128413-200213470-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Heinzerling, L. M., R. Dummer, R. G. Panizzon, P. H. Bloch, R. Barbezat, and G. Burg. "Prevention Campaign against Skin Cancer." Dermatology 205, no. 3 (2002): 229–33. http://dx.doi.org/10.1159/000065848.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Sinclair, C., and P. Foley. "Skin cancer prevention in Australia." British Journal of Dermatology 161 (November 2009): 116–23. http://dx.doi.org/10.1111/j.1365-2133.2009.09459.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Reding, Douglas I., Virginia Fischer, Paul Gunderson, Karen Lappe, Henry Anderson, and Geoffrey Calvert. "Teens Teach Skin Cancer Prevention." Journal of Rural Health 12 (December 1996): 265–72. http://dx.doi.org/10.1111/j.1748-0361.1996.tb00815.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Farmer, Kathryn L., Michelle Goller, and Scott M. Lippman. "Prevention of Nonmelanoma Skin Cancer." Clinics in Plastic Surgery 24, no. 4 (October 1997): 663–71. http://dx.doi.org/10.1016/s0094-1298(20)32289-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Marks, R. "Primary prevention of skin cancer." BMJ 309, no. 6950 (July 30, 1994): 285–86. http://dx.doi.org/10.1136/bmj.309.6950.285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Jackmuth, R. "Primary prevention of skin cancer." Melanoma Research 6, SUPPLEMENT 1 (September 1996): S57. http://dx.doi.org/10.1097/00008390-199609001-00143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Harris, Robin B., and David S. Alberts. "Strategies for skin cancer prevention." International Journal of Dermatology 43, no. 4 (April 2004): 243–51. http://dx.doi.org/10.1111/j.1365-4632.2004.01966.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Correia, Osvaldo, Bernardo Correia, and Ana Filipa Duarte. "A Skin Cancer Prevention Campaign." JAMA Dermatology 153, no. 2 (February 1, 2017): 129. http://dx.doi.org/10.1001/jamadermatol.2016.4232.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Wickersham, Hannah, and Lori Boright. "Skin Cancer Prevention and Detection." Home Healthcare Now 40, no. 6 (November 2022): 344–45. http://dx.doi.org/10.1097/nhh.0000000000001120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Saha, Kamalika, Thomas J. Hornyak, and Richard L. Eckert. "Epigenetic Cancer Prevention Mechanisms in Skin Cancer." AAPS Journal 15, no. 4 (August 1, 2013): 1064–71. http://dx.doi.org/10.1208/s12248-013-9513-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Andrews, Hilary. "Skin and sun awareness and skin cancer prevention." British Journal of Healthcare Assistants 6, no. 12 (December 2012): 582–88. http://dx.doi.org/10.12968/bjha.2012.6.12.582.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Curry, Susan J., Alex H. Krist, and Douglas K. Owens. "Skin Self-examination for Skin Cancer Prevention—Reply." JAMA 320, no. 7 (August 21, 2018): 721. http://dx.doi.org/10.1001/jama.2018.8024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Ramstack, J. L., S. E. White, K. S. Hazelkorn, and F. L. Meyskens. "Sunshine and skin cancer: A school-based skin cancer prevention project." Journal of Cancer Education 1, no. 3 (1986): 169–76. http://dx.doi.org/10.1080/08858198609527829.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Oh, Byung-Ho. "Pathogenesis and prevention of skin cancer." Journal of the Korean Medical Association 61, no. 11 (2018): 644. http://dx.doi.org/10.5124/jkma.2018.61.11.644.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Sharpe, Graham. "Skin cancer: prevalence, prevention and treatment." Clinical Medicine 6, no. 4 (July 1, 2006): 333–34. http://dx.doi.org/10.7861/clinmedicine.6-4-333.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Telfer, Nicholas R. "Skin cancer: prevalence, prevention and treatment." Clinical Medicine 6, no. 6 (November 1, 2006): 622.1–622. http://dx.doi.org/10.7861/clinmedicine.6-6-622.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Hartzel, J., and G. Heffels. "Urgent messages in skin cancer prevention." Melanoma Research 6, SUPPLEMENT 1 (September 1996): S9. http://dx.doi.org/10.1097/00008390-199609001-00024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Grob, J. J., and J. J. Bonerandi. "Is skin cancer prevention cost-effective?" Melanoma Research 6, SUPPLEMENT 1 (September 1996): S13. http://dx.doi.org/10.1097/00008390-199609001-00033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

RAMPEN, F. "S215 Nonmelanoma skin cancer and prevention." Journal of the European Academy of Dermatology and Venereology 9 (September 1997): S49—S50. http://dx.doi.org/10.1016/s0926-9959(97)89039-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Loescher, Lois J. "Skin cancer prevention and detection update." Seminars in Oncology Nursing 9, no. 3 (August 1993): 184–87. http://dx.doi.org/10.1016/s0749-2081(05)80034-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Moon, Thomas E., Norman Levine, Brenda Cartmel, and Jerry L. Bangert. "Retinoids in prevention of skin cancer." Cancer Letters 114, no. 1-2 (March 1997): 203–5. http://dx.doi.org/10.1016/s0304-3835(97)04663-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Lamberg, Lynne. "Diet May Affect Skin Cancer Prevention." JAMA 279, no. 18 (May 13, 1998): 1427. http://dx.doi.org/10.1001/jama.279.18.1427-jmn0513-4-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Linos, Eleni, Kenneth A. Katz, and Graham A. Colditz. "Skin Cancer—The Importance of Prevention." JAMA Internal Medicine 176, no. 10 (October 1, 2016): 1435. http://dx.doi.org/10.1001/jamainternmed.2016.5008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Bleakley, Amy, DeAnn Lazovich, Amy B. Jordan, and Karen Glanz. "Compensation Behaviors and Skin Cancer Prevention." American Journal of Preventive Medicine 55, no. 6 (December 2018): 848–55. http://dx.doi.org/10.1016/j.amepre.2018.06.019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Stratton, Steven P. "Prevention of non-melanoma skin cancer." Current Oncology Reports 3, no. 4 (August 2001): 295–300. http://dx.doi.org/10.1007/s11912-001-0080-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Koh, Howard K., and Alan C. Geller. "Skin cancer prevention comes of age." American Journal of Preventive Medicine 27, no. 5 (December 2004): 484–85. http://dx.doi.org/10.1016/j.amepre.2004.08.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Henrikson, Nora B., Caitlin C. Morrison, Paula R. Blasi, Matt Nguyen, Kendall C. Shibuya, and Carrie D. Patnode. "Behavioral Counseling for Skin Cancer Prevention." JAMA 319, no. 11 (March 20, 2018): 1143. http://dx.doi.org/10.1001/jama.2017.21630.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Jin, Jill. "Behavioral Counseling for Skin Cancer Prevention." JAMA 319, no. 11 (March 20, 2018): 1176. http://dx.doi.org/10.1001/jama.2018.1624.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Pentland, Alice P. "Cyclooxygenase Inhibitors for Skin Cancer Prevention." Archives of Dermatology 138, no. 6 (June 1, 2002): 823. http://dx.doi.org/10.1001/archderm.138.6.823.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Wheless, L., I. Ruczinski, R. M. Alani, S. Clipp, J. Hoffman-Bolton, T. J. Jorgensen, N. J. Liegeois, P. T. Strickland, and A. J. Alberg. "The Association between Skin Characteristics and Skin Cancer Prevention Behaviors." Cancer Epidemiology Biomarkers & Prevention 18, no. 10 (September 15, 2009): 2613–19. http://dx.doi.org/10.1158/1055-9965.epi-09-0383.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Vinzón, Sabrina E., and Frank Rösl. "HPV vaccination for prevention of skin cancer." Human Vaccines & Immunotherapeutics 11, no. 2 (February 2015): 353–57. http://dx.doi.org/10.4161/21645515.2014.983858.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Mayer, J. A., L. Eckhardt, B. M. Stepanski, J. F. Sallis, J. P. Elder, D. J. Slymen, L. Creech, et al. "Promoting skin cancer prevention counseling by pharmacists." American Journal of Public Health 88, no. 7 (July 1998): 1096–99. http://dx.doi.org/10.2105/ajph.88.7.1096.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography